WASHINGTON--(BUSINESS WIRE)--America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the latest Medicines in Development report by the Pharmaceutical Research and Manufacturers of America (PhRMA). A second report, a PhRMA-sponsored white paper by Boston Healthcare Associates, Inc. (BHA), “The Value of Innovation in HIV/AIDS Therapy,” highlights the progress in HIV/AIDS treatment and its impact on patients afflicted with the disease.
Help employers find you! Check out all the jobs and post your resume.
